Cargando…

Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece

Given the concerns of waning immunity from the primary COVID-19 vaccines and the first booster dose, we conducted an online cross-sectional study in May 2022 to investigate willingness to receive a second COVID-19 booster dose or a new COVID-19 vaccine and its associated factors. Overall, 62% of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Galanis, Petros, Vraka, Irene, Katsiroumpa, Aglaia, Siskou, Olga, Konstantakopoulou, Olympia, Katsoulas, Theodoros, Mariolis-Sapsakos, Theodoros, Kaitelidou, Daphne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317544/
https://www.ncbi.nlm.nih.gov/pubmed/35891225
http://dx.doi.org/10.3390/vaccines10071061
_version_ 1784755083194400768
author Galanis, Petros
Vraka, Irene
Katsiroumpa, Aglaia
Siskou, Olga
Konstantakopoulou, Olympia
Katsoulas, Theodoros
Mariolis-Sapsakos, Theodoros
Kaitelidou, Daphne
author_facet Galanis, Petros
Vraka, Irene
Katsiroumpa, Aglaia
Siskou, Olga
Konstantakopoulou, Olympia
Katsoulas, Theodoros
Mariolis-Sapsakos, Theodoros
Kaitelidou, Daphne
author_sort Galanis, Petros
collection PubMed
description Given the concerns of waning immunity from the primary COVID-19 vaccines and the first booster dose, we conducted an online cross-sectional study in May 2022 to investigate willingness to receive a second COVID-19 booster dose or a new COVID-19 vaccine and its associated factors. Overall, 62% of the participants were willing to be vaccinated, 25.8% were unsure, and 12.3% were unwilling to be vaccinated. The main reasons against accepting a second COVID-19 booster dose/new COVID-19 vaccine were concerns about the side effects and the effectiveness and the opinion that further vaccination is unnecessary. Males, younger individuals, participants without a previous COVID-19 diagnosis, and those with good/very good self-perceived physical health were significantly more frequently willing to receive a second COVID-19 booster dose or a new COVID-19 vaccine. Additionally, increased fear of the COVID-19, increased trust in COVID-19 vaccinations, and decreased fear of a second booster dose or a new COVID-19 vaccine was associated with increased willingness. Our results show some hesitancy and unwillingness toward further COVID-19 vaccination and indicate that the fear of COVID-19 and trust in COVID-19 vaccination affects public opinion.
format Online
Article
Text
id pubmed-9317544
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93175442022-07-27 Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece Galanis, Petros Vraka, Irene Katsiroumpa, Aglaia Siskou, Olga Konstantakopoulou, Olympia Katsoulas, Theodoros Mariolis-Sapsakos, Theodoros Kaitelidou, Daphne Vaccines (Basel) Article Given the concerns of waning immunity from the primary COVID-19 vaccines and the first booster dose, we conducted an online cross-sectional study in May 2022 to investigate willingness to receive a second COVID-19 booster dose or a new COVID-19 vaccine and its associated factors. Overall, 62% of the participants were willing to be vaccinated, 25.8% were unsure, and 12.3% were unwilling to be vaccinated. The main reasons against accepting a second COVID-19 booster dose/new COVID-19 vaccine were concerns about the side effects and the effectiveness and the opinion that further vaccination is unnecessary. Males, younger individuals, participants without a previous COVID-19 diagnosis, and those with good/very good self-perceived physical health were significantly more frequently willing to receive a second COVID-19 booster dose or a new COVID-19 vaccine. Additionally, increased fear of the COVID-19, increased trust in COVID-19 vaccinations, and decreased fear of a second booster dose or a new COVID-19 vaccine was associated with increased willingness. Our results show some hesitancy and unwillingness toward further COVID-19 vaccination and indicate that the fear of COVID-19 and trust in COVID-19 vaccination affects public opinion. MDPI 2022-06-30 /pmc/articles/PMC9317544/ /pubmed/35891225 http://dx.doi.org/10.3390/vaccines10071061 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Galanis, Petros
Vraka, Irene
Katsiroumpa, Aglaia
Siskou, Olga
Konstantakopoulou, Olympia
Katsoulas, Theodoros
Mariolis-Sapsakos, Theodoros
Kaitelidou, Daphne
Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
title Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
title_full Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
title_fullStr Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
title_full_unstemmed Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
title_short Predictors of Willingness of the General Public to Receive a Second COVID-19 Booster Dose or a New COVID-19 Vaccine: A Cross-Sectional Study in Greece
title_sort predictors of willingness of the general public to receive a second covid-19 booster dose or a new covid-19 vaccine: a cross-sectional study in greece
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9317544/
https://www.ncbi.nlm.nih.gov/pubmed/35891225
http://dx.doi.org/10.3390/vaccines10071061
work_keys_str_mv AT galanispetros predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT vrakairene predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT katsiroumpaaglaia predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT siskouolga predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT konstantakopoulouolympia predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT katsoulastheodoros predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT mariolissapsakostheodoros predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece
AT kaitelidoudaphne predictorsofwillingnessofthegeneralpublictoreceiveasecondcovid19boosterdoseoranewcovid19vaccineacrosssectionalstudyingreece